{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:17:41Z","timestamp":1789265861638,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"am","delay-in-days":337,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93019C00052"],"award-info":[{"award-number":["75N93019C00052"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008065","name":"Georgia Research Alliance","doi-asserted-by":"publisher","award":["GRA-001"],"award-info":[{"award-number":["GRA-001"]}],"id":[{"id":"10.13039\/100008065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.vaccine.2025.127449","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T22:56:09Z","timestamp":1751583369000},"page":"127449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Self-amplifying mRNA expressing COBRA hemagglutinin elicits long-lasting, broadly reactive antibodies against seasonal influenza A viruses"],"prefix":"10.1016","volume":"62","author":[{"given":"Spencer R.","family":"Pierce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Caetano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Prots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Carlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey M.","family":"Cervantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy R.","family":"Rappaport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciaran D.","family":"Scallan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Jooss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted M.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2025.127449_bb0005","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/v8040096","article-title":"Current approaches for diagnosis of influenza virus infections in humans","volume":"8","author":"Vemula","year":"2016","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127449_bb0010","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/irv.12963","article-title":"The economic burden of influenza among adults aged 18 to 64: a systematic literature review","volume":"16","author":"de Courville","year":"2022","journal-title":"Influenza Other Respi Viruses"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127449_bb0015","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/irv.12486","article-title":"Annual estimates of the burden of seasonal influenza in the United States: a tool for strengthening influenza surveillance and preparedness","volume":"12","author":"Rolfes","year":"2018","journal-title":"Influenza Other Respi Viruses"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127449_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7005a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices, United States, 2021-22 influenza season","volume":"70","author":"Grohskopf","year":"2021","journal-title":"MMWR Recomm Rep"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127449_bb0025","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3390\/v4091438","article-title":"Evasion of influenza A viruses from innate and adaptive immune responses","volume":"4","author":"van de Sandt","year":"2012","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127449_bb0030","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01652-21","article-title":"Bivalent H1 and H3 COBRA recombinant hemagglutinin vaccines elicit seroprotective antibodies against H1N1 and H3N2 influenza viruses from 2009 to 2019","volume":"96","author":"Allen","year":"2022","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127449_bb0035","doi-asserted-by":"crossref","first-page":"15911","DOI":"10.1038\/s41598-023-43003-2","article-title":"A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages","volume":"13","author":"Carlock","year":"2023","journal-title":"Sci Rep"},{"issue":"16","key":"10.1016\/j.vaccine.2025.127449_bb0040","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/j.vaccine.2011.01.100","article-title":"A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets","volume":"29","author":"Giles","year":"2011","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.vaccine.2025.127449_bb0045","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01581-17","article-title":"Computationally optimized broadly reactive hemagglutinin elicits hemagglutination inhibition antibodies against a panel of H3N2 influenza virus cocirculating variants","volume":"91","author":"Wong","year":"2017","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.vaccine.2025.127449_bb0050","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00759-21","article-title":"Universal influenza virus neuraminidase vaccine elicits protective immune responses against human seasonal and pre-pandemic strains","volume":"95","author":"Skarlupka","year":"2021","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127449_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/v15010203","article-title":"Evaluation of pre-pandemic trivalent COBRA HA vaccine in mice pre-immune to historical H1N1 and H3N2 influenza viruses","volume":"15","author":"Ge","year":"2023","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127449_bb0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines \u2014 a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127449_bb0065","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.ymthe.2022.01.001","article-title":"A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models","volume":"30","author":"Maruggi","year":"2022","journal-title":"Mol Ther"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127449_bb0070","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.ymthe.2021.04.001","article-title":"A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice","volume":"29","author":"de Alwis","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2025.127449_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101262","article-title":"Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial","volume":"44","author":"Pollock","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127449_bb0080","article-title":"An update on self-amplifying mRNA vaccine development","volume":"9","author":"Blakney","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127449_bb0085","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1038\/s41467-022-31005-z","article-title":"Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection","volume":"13","author":"Rappaport","year":"2022","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127449_bb0090","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/s41591-022-01937-6","article-title":"Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results","volume":"28","author":"Palmer","year":"2022","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127449_bb0095","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1038\/s41467-023-39053-9","article-title":"GRT-R910: a self-amplifying mRNA SARS-CoV-2 vaccine boosts immunity for >\/=6 months in previously-vaccinated older adults","volume":"14","author":"Palmer","year":"2023","journal-title":"Nat Commun"},{"issue":"15","key":"10.1016\/j.vaccine.2025.127449_bb0100","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1093\/bioinformatics\/btu192","article-title":"Codon optimization OnLine (COOL): a web-based multi-objective optimization platform for synthetic gene design","volume":"30","author":"Chin","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2025.127449_bb0105","series-title":"Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza: WHO Global Influenza Surveillance Network","author":"Organization, W.H","year":"2011"},{"key":"10.1016\/j.vaccine.2025.127449_bb0110","series-title":"Guideline on Influenza Vaccines\u2014Non-clinical and Clinical Module","first-page":"1","volume":"44","author":"Use, C.f.M.P.f.H","year":"2016"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127449_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/v15020432","article-title":"Recombinant protein vaccines formulated with enantio-specific cationic lipid R-DOTAP induce protective cellular and antibody-mediated immune responses in mice","volume":"15","author":"Gandhapudi","year":"2023","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127449_bb0120","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00781-24","article-title":"rAAV expressing a COBRA-designed influenza hemagglutinin generates a protective and durable adaptive immune response with a single dose","volume":"98","author":"Wiggins","year":"2024","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127449_bb0125","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01432-19","article-title":"N-linked glycans and K147 residue on hemagglutinin synergize to elicit broadly reactive H1N1 influenza virus antibodies","volume":"94","author":"Huang","year":"2020","journal-title":"J Virol"},{"issue":"38","key":"10.1016\/j.vaccine.2025.127449_bb0130","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1016\/j.vaccine.2017.07.107","article-title":"Broadened immunity and protective responses with emulsion-adjuvanted H5 COBRA-VLP vaccines","volume":"35","author":"Allen","year":"2017","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127449_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204284","article-title":"Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses","volume":"13","author":"Allen","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.127449_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1334670","article-title":"mRNA vaccines encoding computationally optimized hemagglutinin elicit protective antibodies against future antigenically drifted H1N1 and H3N2 influenza viruses isolated between 2018-2020","volume":"15","author":"Allen","year":"2024","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127449_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008109","article-title":"Childhood immune imprinting to influenza a shapes birth year-specific risk during seasonal H1N1 and H3N2 epidemics","volume":"15","author":"Gostic","year":"2019","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127449_bb0150","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132155","article-title":"Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination","volume":"5","author":"Abreu","year":"2020","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127449_bb0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/vaccines8020173","article-title":"Immune imprinting in the influenza ferret model","volume":"8","author":"Skarlupka","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.127449_bb0160","series-title":"Summary: \u2018Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)\u2014United States, 2023-24\u2019","author":"Prevention, C.f.D.C.a","year":"2023"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127449_bb0165","article-title":"Waning vaccine protection against influenza among Department of Defense Adult Beneficiaries in the United States, 2016-2017 through 2019-2020 influenza seasons","volume":"10","author":"Hu","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127449_bb0170","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/vaccines6020028","article-title":"Immune history and influenza vaccine effectiveness","volume":"6","author":"Lewnard","year":"2018","journal-title":"Vaccines"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127449_bb0175","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/INF.0b013e3182367662","article-title":"Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children","volume":"30","author":"Black","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127449_bb0180","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/infdis\/jiu186","article-title":"Association between antibody titers and protection against influenza virus infection within households","volume":"210","author":"Tsang","year":"2014","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127449_bb0185","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.it.2017.08.003","article-title":"From original antigenic sin to the universal influenza virus vaccine","volume":"39","author":"Henry","year":"2018","journal-title":"Trends Immunol"},{"issue":"36","key":"10.1016\/j.vaccine.2025.127449_bb0190","doi-asserted-by":"crossref","first-page":"14604","DOI":"10.1073\/pnas.1209367109","article-title":"Nonviral delivery of self-amplifying RNA vaccines","volume":"109","author":"Geall","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2025.127449_bb0195","series-title":"Design and characterization of computationally optimized broadly reactive antigen (cobra) vaccines against human seasonal influenza A (H3N2) viruses","author":"Allen","year":"2021"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127449_bb0200","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrmicro.2017.118","article-title":"The evolution of seasonal influenza viruses","volume":"16","author":"Petrova","year":"2018","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127449_bb0205","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3390\/vaccines9070793","article-title":"Next generation of computationally optimized broadly reactive HA vaccines elicited cross-reactive immune responses and provided protection against H1N1 virus infection","volume":"9","author":"Huang","year":"2021","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127449_bb0210","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1038\/s41598-020-79590-7","article-title":"Next generation methodology for updating HA vaccines against emerging human seasonal influenza A (H3N2) viruses","volume":"11","author":"Allen","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.127449_bb0215","series-title":"Information for the 2023-2024 Flu Season","author":"CDC","year":"2024"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127449_bb0220","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/s41598-023-51024-0","article-title":"Multivalent next generation influenza virus vaccines protect against seasonal and pre-pandemic viruses","volume":"14","author":"Uno","year":"2024","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127449_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.1065","article-title":"Using EMBL-EBI services via web interface and programmatically via web services","volume":"4","author":"Madeira","year":"2024","journal-title":"Curr Protoc"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25007467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25007467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T03:18:17Z","timestamp":1766546297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25007467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":45,"alternative-id":["S0264410X25007467"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127449","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-amplifying mRNA expressing COBRA hemagglutinin elicits long-lasting, broadly reactive antibodies against seasonal influenza A viruses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127449","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"127449"}}